Pharma Front Group Hosted House Staffers at Luxury Resort Before BBB Vote
Days before the House voted on the Build Back Better Act, Center Forward hosted dozens of congressional staffers to discuss policy issues with lobbyists.
Page 2
Days before the House voted on the Build Back Better Act, Center Forward hosted dozens of congressional staffers to discuss policy issues with lobbyists.
The Senate braces for a showdown over expanding Medicare to include dental and vision benefits after healthcare industry lobbyists have bundled six-figure donations for Democrats’ campaign arms.
House Budget Chair John Yarmuth is a frequent stock trader who recently purchased shares in companies that are lobbying against the Democrats' budget plan.
Leaders of a centrist advocacy group with funding from the pharmaceutical industry founded outlet The Well News and have editorial input on its promoted posts.
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
The plan, initiated by the Trump administration in January, would gut a key government power for making sure taxpayer-funded pharmaceuticals are available to the public at reasonable prices.
An anti-government waste group is helping its Big Pharma funder oppose a discount drug program that doesn’t cost the government a penny.
Center Forward, a "dark money" group with major funding from Big Pharma, is running a Facebook ad campaign touting the pharmaceutical industry as its super PAC spends millions to re-elect Blue Dog Democrats.